Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

University of British Columbia

$49,020.00

Harnessing virus-virus interactions to combat antiviral resistance evolution

EF 2025-26

Résumé
Viruses are often thought of as solitary entities. However, viruses frequently interact with other viruses, both of the same and different species. As a result, many important aspects of viral infections, such as their pathogenesis, emergence, or potential to evolve in response to therapeutics, depends not just on one viral genotype but on the community of interacting viruses. Viruses can therefore be considered highly social, in the evolutionary sense. Mechanistically, virus-virus interactions can affect every stage of the viral life cycle, influencing both the outcomes of infections and the ways in which viral populations change over time. As a result, understanding virus-virus interactions is critical to combatting the growing threat of antiviral resistance. However, this important area has been studied less than other areas, because it requires collaboration between scientists from different disciplines. The main objective of our meeting is to foster collaborations between diverse researchers who study topics related to how virus-virus interactions influence antiviral resistance evolution. There are three clear areas through which the results of this meeting will improve our understanding and ability to fight antiviral resistance: 1. We will explore how to use virus-virus interactions to combat viral infections as a new form of antiviral therapeutic; 2. We will study how to use virus-virus interactions to improve clinical diagnostics, thus making more effective use of our existing antivirals; 3. We will develop virus-virus interactions into tools for tracking the transmission of viral infections outside the clinic, including in the environment and in animal populations.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
531418
Name
Leeks Asher
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
Harnessing virus-virus interactions to combat antiviral resistance evolution
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$49,020
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Antimicrobial Resistance; Antiviral Resistance; Antiviral Therapeutics; Clinical Biomarkers; Evolution Of Resistance; One Health; Viral Emergence And Evolution; Virology; Virus-Virus Interactions
Abstract
Viruses are often thought of as solitary entities. However, viruses frequently interact with other viruses, both of the same and different species. As a result, many important aspects of viral infections, such as their pathogenesis, emergence, or potential to evolve in response to therapeutics, depends not just on one viral genotype but on the community of interacting viruses. Viruses can therefore be considered highly social, in the evolutionary sense. Mechanistically, virus-virus interactions can affect every stage of the viral life cycle, influencing both the outcomes of infections and the ways in which viral populations change over time. As a result, understanding virus-virus interactions is critical to combatting the growing threat of antiviral resistance. However, this important area has been studied less than other areas, because it requires collaboration between scientists from different disciplines. The main objective of our meeting is to foster collaborations between diverse researchers who study topics related to how virus-virus interactions influence antiviral resistance evolution. There are three clear areas through which the results of this meeting will improve our understanding and ability to fight antiviral resistance: 1. We will explore how to use virus-virus interactions to combat viral infections as a new form of antiviral therapeutic; 2. We will study how to use virus-virus interactions to improve clinical diagnostics, thus making more effective use of our existing antivirals; 3. We will develop virus-virus interactions into tools for tracking the transmission of viral infections outside the clinic, including in the environment and in animal populations.
Competitiondate
202506
Approvedterm2
1 yr 0 mth
Pinamesdelim
Leeks, Asher
Approvedterm
1 an 0 mois
Cihrcontribution2
MI #3~ $49,020~ $0~